The American Society of Clinical Oncology (ASCO), a medical body comprised of physicians around the nation, establishes and updates treatment…
Patients with a newly identified subtype of triple-negative breast cancer (TNBC), referred to as BRCA-deficient subtype, demonstrate a markedly higher…
Patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) who have genetic mutations, including the TP53 mutation, that typically…
Among men with early prostate cancer that is detected through prostate-specific antigen (PSA) testing, treatment with either surgery, radiation therapy,…
The House and Senate have overwhelmingly passed the 21st Century Cures Bill. The bill will now go to Obama who…
The following article from CancerConnect reviews some mind-body techniques to help ease sleep disturbances and insomnia in cancer survivors: http://news.cancerconnect.com/cancer-survivorship-insomnia-sleep-disturbance/…
The addition of LEE011 (ribociclib) to Femara® (letrozole) significantly improved the survival time without cancer progression compared to letrozole only…
The addition of abiraterone acetate to standard therapy significantly delays cancer progression among patients with newly diagnosed prostate cancer that…
The agent Revlimid (lenalidomide) reduces the need for blood transfusions among patients with lower-risk, non-del (5q) myelodysplastic syndromes who are…
The immune-stimulating agent, Opdivo® (nivolumab), appears to significantly improve overall survival among patients with advanced stomach cancer for which no…